Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Pacific Biosciences of California, Inc. (PACB) had Debt to Equity Ratio of 10.51 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$39.77M |
|
$-41.93M |
|
$25.08M |
|
$14.68M |
|
$84.62M |
|
$-44.85M |
|
$2.96M |
|
$-41.90M |
|
$-41.90M |
|
$-41.93M |
|
$-41.93M |
|
$-41.93M |
|
$-41.93M |
|
$-44.85M |
|
$-41.55M |
|
300.16M |
|
300.16M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$413.40M |
|
$23.10M |
|
$412.07M |
|
$825.47M |
|
$59.75M |
|
$646.44M |
|
$704.23M |
|
$763.98M |
|
$61.49M |
|
$-273.44M |
|
$61.49M |
|
300.35M |
|
| Cash Flow Statement Financials | |
$-73.43M |
|
$70.52M |
|
$1.96M |
|
$57.59M |
|
$56.63M |
|
$-0.96M |
|
$21.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.92 |
|
-- |
|
-- |
|
0.91 |
|
|
Debt to Equity Ratio |
10.51 |
36.93% |
|
-112.79% |
|
-112.79% |
|
-- |
|
-105.35% |
|
-105.44% |
|
$-75.37M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.47 |
|
1.23 |
|
73.01 |
|
-68.19% |
|
15.33% |
|
-5.08% |
|
-5.92% |
|
$0.20 |
|
$-0.25 |
|
$-0.24 |
|